News

Video

ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases

Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.

Taylor Strange, DO, shared insights on improving astigmatism outcomes using the LENSAR Ally femtosecond laser system in light adjustable lens (LAL) patients in a presentation at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California.

Strange outlined the motivation behind transitioning away from manual techniques. “I was motivated to explore femtosecond laser astigmatism correction, because prior to me adopting femtosecond laser vision correction, I would do manual LRIs, and my manual LRIs weren't that effective. My enhancement rate was too high for me, unacceptable at about 10%, so I wanted to look into technology that would allow me to deliver a better, premium outcome with less enhancements.”

His study demonstrated significant benefits with femtosecond laser-assisted correction. “It was great to see that the reduction in the astigmatism and the number of adjustments I did with light adjustable lens was significantly improved statistically in my study.” Patients who received astigmatism correction with the LENSAR Ally system required fewer LAL adjustments, translating into tangible efficiency gains. “The outcomes of this study would really help a surgeon to adopting into femtosecond laser treatment, especially for light adjustable lens patients, to really look forward to having less adjustments performed on these patients, which means less chair time and quicker to their end point.”

Reflecting on his experience, Strange noted, “I noticed a difference compared to not doing femtosecond laser, that I got much more improvement, again, with less chair time and better results.” He emphasized the broader impact on premium cataract surgery: “I'm a big proponent of using the Ally LENSAR system for all premium IOLs. It gives you better astigmatism management, which you can get to your refractive outcome better in my hands versus using manual LRIs.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.